This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of SPIRIVA RESPIMAT 2.5 MCG INH 4GM. The $2,266.13 firm fixed price delivery order contract has a period of performance through December 5, 2024. As the prime contractor, Amerisourcebergen will be responsible for delivering these pharmaceutical products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military healthcare system globally.
Generated 3/5/25, 10:07 AM